Type |
Details |
Score |
Allele |
Name: |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); endonuclease-mediated mutation 2, Cyagen Biosciences |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Allele |
Name: |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); endonuclease-mediated mutation 4, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); endonuclease-mediated mutation 3, Cyagen Biosciences |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Allele |
Name: |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); endonuclease-mediated mutation 4, Cyagen Biosciences |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
C57BL/6N-Cd74/H |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Allele |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Ari Waisman |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, Christophe Benoist and Diane Mathis |
Allele Type: |
Transgenic |
Attribute String: |
Transactivator |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, Toshiyuki Fukada |
Allele Type: |
Transgenic |
Attribute String: |
Recombinase |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, congenic, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, major histocompatibility congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
either: (involves: 129/Sv * B10.BR) or (involves: 129/Sv * C57BL/6) |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S/SvEv * C57BL/6J |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
B6.129S-Cd74 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S/SvEv * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S/SvEv * BALB/cAn |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S/SvEv * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S/SvEv * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S/SvEv * BALB/c * C57BL |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S/SvEv * C57BL * C57BL/10 * C57BR |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S/SvEv |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S2/SvPas |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S2/SvPas |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
B6.129S2-Cd74 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
B6.129S-Cd74/J |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S2/SvPas * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Stumptner-Cuvelette P |
Year: |
2002 |
Journal: |
Biochim Biophys Acta |
Title: |
Multiple roles of the invariant chain in MHC class II function. |
Volume: |
1542 |
Issue: |
1-3 |
Pages: |
1-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schröder B |
Year: |
2016 |
Journal: |
Biochim Biophys Acta |
Title: |
The multifaceted roles of the invariant chain CD74--More than just a chaperone. |
Volume: |
1863 |
Issue: |
6 Pt A |
Pages: |
1269-81 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
CD74 is expressed on antigen-presenting cells and was initially demonstrated to function as an MHC class II chaperone []. It was originally described as the MHC class II-associated invariant chain and its binding to MHC II alpha and beta chains is crucial for the MHCII antigen presentation pathway. Besides chaperone function, it is also involved in the regulation of endosomal trafficking, cell migration and cellular signalling as surface receptor of the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) []. Macrophage migration inhibitory factor binding to CD74 induces its intramembrane cleavage and the release of its cytosolic intracellular domain (CD74-ICD), which interacts with the transcription factors RUNX (Runt related transcription factor) and NF-kappaB and binds to proximal and distal regulatory sites enriched for genes involved in apoptosis, immune response, and cell migration. Recently, CD74 has been associated with tumor progression and metastasis []. |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, congenic, transgenic |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 10G, Naoko Nakano |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 29, Naoko Nakano |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion #, Christophe Benoist and Diane Mathis |
Allele Type: |
Transgenic |
Attribute String: |
Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 125, Tetsuo Noda |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Johannes Herkel |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Inserted expressed sequence |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, major histocompatibility congenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, congenic, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, mutant strain, major histocompatibility congenic, congenic |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd1d1/Cd1d1 Cd74/Cd74 |
Background: |
involves: 129S2/SvPas * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 Sppl2a/Sppl2a |
Background: |
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 Sppl2a/Sppl2a |
Background: |
B6.129-Sppl2a Cd74 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, congenic, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, mutant strain, coisogenic |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(SFTPC-CD74/ROS1)125Tno/? |
Background: |
C57BL/6J-Tg(SFTPC-CD74/ROS1)125Tno |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
H2-DMa/H2-DMa Cd74/Cd74 |
Background: |
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 H2-DMa/H2-DMa |
Background: |
involves: 129S2/SvPas * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 |
Background: |
involves: 129S/SvEv * C57BL/6 |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 H2-DMa/H2-DMa |
Background: |
involves: 129S/SvEv * BALB/c |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 H2-DMa/H2-DMa Tg(CD74)AR194Ayr/? |
Background: |
involves: 129S/SvEv * 129S4/SvJae * C57BL/6J * DBA/2J |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 Tap1/Tap1 |
Background: |
involves: 129S2/SvPas * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74 H2-DMa/H2-DMa Tg(CD74*)1Ayr/? |
Background: |
involves: 129S/SvEv * 129S4/SvJae * C57BL/6J * DBA/2J |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74<+> |
Background: |
involves: 129S/SvEv |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd19/Cd19<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, targeted mutation, mutant stock |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Smim3/Smim3<+> Cd74/Cd74<+> |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The CD74 antigen (also known as H-2 class II histocompatibility antigen gamma chain, MHC class II-associated invariant chain, Ia antigen-associated invariant chain, or Ii) plays a key role in MHC class II antigen processing: it stabilises peptide-free class II alpha/beta heterodimers in a nonameric (α-β-gamma)3 complex after their synthesis, and directs transport of the complex from the endoplasmic reticulum to compartments where peptide loading of class II takes place []. CD74/Ii is a single-pass type II membrane protein containing a thyroglobulin type-1 domain. The structure of the trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii has been determined by NMR []. The molecule is cylindrical in shape and reveals conserved molecular surfaces that may mediate interactions between Ii and class II molecules []. |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, transgenic, variant allele |
|
•
•
•
•
•
|
Publication |
First Author: |
Obst R |
Year: |
2005 |
Journal: |
J Exp Med |
Title: |
Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. |
Volume: |
201 |
Issue: |
10 |
Pages: |
1555-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Inoue M |
Year: |
2016 |
Journal: |
Carcinogenesis |
Title: |
Mouse models for ROS1-fusion-positive lung cancers and their application to the analysis of multikinase inhibitor efficiency. |
Volume: |
37 |
Issue: |
5 |
Pages: |
452-60 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd19/Cd19<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Il10/Il10 |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Smim3/Smim3<+> Cd74/Cd74<+> Lmo2/Lmo2<+> |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd74/Cd74<+> Lmo2/Lmo2<+> Smim3/Smim3<+> |
Background: |
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Smim3/Smim3<+> Cd74/Cd74<+> Lmo2/Lmo2<+> Trp53/Trp53<+> |
Background: |
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Smim3/Smim3<+> Cd74/Cd74<+> Lmo2/Lmo2<+> Trp53/Trp53 |
Background: |
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(CAG-cat,-EGFP)39Miya/? Tg(Cd74-cre)#Tfk/? |
Background: |
involves: C57BL/6 * DBA/2NJcl |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Qiu Z |
Year: |
2024 |
Journal: |
Sci Adv |
Title: |
IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes. |
Volume: |
10 |
Issue: |
28 |
Pages: |
eadk2091 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kong XF |
Year: |
2018 |
Journal: |
Nat Immunol |
Title: |
Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. |
Volume: |
19 |
Issue: |
9 |
Pages: |
973-985 |
|
•
•
•
•
•
|
Publication |
First Author: |
Merk M |
Year: |
2011 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). |
Volume: |
108 |
Issue: |
34 |
Pages: |
E577-85 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
279
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
279
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamashiro H |
Year: |
2002 |
Journal: |
Int Immunol |
Title: |
Development of CD25(+) T cells secreting transforming growth factor-beta1 by altered peptide ligands expressed as self-antigens. |
Volume: |
14 |
Issue: |
8 |
Pages: |
857-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Han S |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery. |
Volume: |
107 |
Issue: |
47 |
Pages: |
20453-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Leng L |
Year: |
2011 |
Journal: |
J Immunol |
Title: |
A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice. |
Volume: |
186 |
Issue: |
1 |
Pages: |
527-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bernhagen J |
Year: |
2007 |
Journal: |
Nat Med |
Title: |
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. |
Volume: |
13 |
Issue: |
5 |
Pages: |
587-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tilstam PV |
Year: |
2021 |
Journal: |
J Clin Invest |
Title: |
MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model. |
Volume: |
131 |
Issue: |
23 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Cortés M |
Year: |
2017 |
Journal: |
EMBO J |
Title: |
Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles. |
Volume: |
36 |
Issue: |
22 |
Pages: |
3336-3355 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou B |
Year: |
2023 |
Journal: |
Eur J Immunol |
Title: |
Prmt5 deficient mouse B cells display RNA processing complexity and slower colorectal tumor progression. |
Volume: |
53 |
Issue: |
10 |
Pages: |
e2250226 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vieira-de-Abreu A |
Year: |
2011 |
Journal: |
Am J Respir Cell Mol Biol |
Title: |
Cross-talk between macrophage migration inhibitory factor and eotaxin in allergic eosinophil activation forms leukotriene Câ‚„-synthesizing lipid bodies. |
Volume: |
44 |
Issue: |
4 |
Pages: |
509-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chatterjee M |
Year: |
2014 |
Journal: |
Circ Res |
Title: |
Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling. |
Volume: |
115 |
Issue: |
11 |
Pages: |
939-49 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kobayashi M |
Year: |
2007 |
Journal: |
J Histochem Cytochem |
Title: |
A distinctive set of genes is upregulated during the inflammation-carcinoma sequence in mouse stomach infected by Helicobacter felis. |
Volume: |
55 |
Issue: |
3 |
Pages: |
263-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nagata Y |
Year: |
2015 |
Journal: |
PLoS One |
Title: |
Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice. |
Volume: |
10 |
Issue: |
2 |
Pages: |
e0115593 |
|
•
•
•
•
•
|
Publication |
First Author: |
Moon HY |
Year: |
2012 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise. |
Volume: |
109 |
Issue: |
32 |
Pages: |
13094-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wong BL |
Year: |
2009 |
Journal: |
Am J Pathol |
Title: |
Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori. |
Volume: |
174 |
Issue: |
4 |
Pages: |
1319-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vandenbark AA |
Year: |
2022 |
Journal: |
Cell Immunol |
Title: |
"Near Cure" treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct. |
Volume: |
378 |
|
Pages: |
104561 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nakamura A |
Year: |
2021 |
Journal: |
Sci Transl Med |
Title: |
Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease. |
Volume: |
13 |
Issue: |
616 |
Pages: |
eabg1210 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pellowe AS |
Year: |
2019 |
Journal: |
FASEB J |
Title: |
Endothelial cell-secreted MIF reduces pericyte contractility and enhances neutrophil extravasation. |
Volume: |
33 |
Issue: |
2 |
Pages: |
2171-2186 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schneppenheim J |
Year: |
2014 |
Journal: |
Mol Cell Biol |
Title: |
The intramembrane proteases signal Peptide peptidase-like 2a and 2b have distinct functions in vivo. |
Volume: |
34 |
Issue: |
8 |
Pages: |
1398-411 |
|
•
•
•
•
•
|